top of page

Jeff Cambra

CEO

Jeffery J. Cambra is a seasoned MedTech executive with more than 28 years of global leadership experience spanning medical devices, drug–device combinations, biologics, and pharmaceuticals. He brings deep expertise in general management, business development, commercialization, and corporate strategy, with a proven track record of building high-performing teams, scaling operations, and driving sustainable growth across public and private companies.

Most recently, Mr. Cambra served as Chief Executive Officer of an early-stage medical device company, where he led the organization through critical growth phases, raised more than CAD $29 million in capital, established ISO 13485/MDSAP–compliant quality systems, advanced global regulatory strategies across Canada, the EU, and the United States, and secured initial commercial distribution and revenue. His leadership emphasized disciplined execution, capital efficiency, and a culture of excellence.

Previously, Mr. Cambra held senior executive roles at leading global healthcare companies, including Vice President positions overseeing multi-billion-dollar businesses with full P&L responsibility, global marketing, product development, and commercialization. His experience spans interventional pain, spine, orthopedics, neuroscience, and musculoskeletal health, with extensive involvement in new product launches, strategic partnerships, and M&A.

Mr. Cambra holds a Bachelor of Science in Health Science and has completed advanced executive leadership training at Stanford University.

Jeff Cambra
Jeff Cambra

DISCLAIMER

Wavegate's EllipseTM platform with Active LoopTM technology has not yet been evaluated by the U.S. Food and Drug Administration and is not currently available for sale in the United States.

  • LinkedIn
  • X
  • Instagram
  • Grey Facebook Icon

© 2026 by WAVEGATE CORPORATION

Ellipse, StimuLux, and Active Loop are trademarks of Wavegate Corporation

Ellipse platform technology is covered by multiple US and International issued patents and patents pending.

​

NEWS RELEASES

Sign up below to receive updates on Wavegate's EllipseTM Technology!

Thanks for submitting!

bottom of page